Summary
- Current Price
- As of today, AVIR price is $4.70, down -0.84% on
- Current Price All-Time High
- AVIR price is currently -95.01% below its historical high of $94.17 set on
- Market Cap
- AVIR current market cap is $376M, up +27.35% over the past 365 days
- Revenue
- AVIR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AVIR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Atea Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AVIR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ateapharma.com |
| Employees | 56 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.70 | ||
| Price, 1D Change | -0.84% | |
| $376M | ||
| - | ||
| - | ||
| 0.65 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.94 | ||
| EPS, 1Y Change | +2.77% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.94 | ||
| EPS Estimate | N/A | -$1.93 |
| EPS Est. Change | N/A | +0.93% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $4.70 | ||
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +112.77% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.81 | -$2.00 | -10.70% | |
| -$1.73 | -$1.94 | -12.64% | |
| -$1.93 | N/A | +0.93% | |
| -$1.39 | N/A | +28.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $30.17M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +29.12% | ||
| +37.03% | ||
| +27.35% | ||
| +31.49% | ||
| 0.00% | ||
| 0.00% | ||
| +2.77% | ||
| -39.54% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $4.70 | ||
| $4.35 | ||
| $4.58 | ||
| $4.45 | ||
| $4.73 | ||
| $0.01 | ||
| 0.65 | ||
| $0.29 | ||
| 49.49 | ||
| 43.75% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.94 | ||
| -$416.00K | ||
| - | ||
| -$180.89M | ||
| - | ||
| -$158.35M | ||
| - | ||
| -$180.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 7.82 | ||
| 7.82 | ||
| - | ||
| - | ||
| 2.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.61 | ||
| -0.64 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $275.43M | ||
| $301.83M | ||
| $315.22M | ||
| $310.99M | ||
| $39.78M | ||
| $39.78M | ||
| $843.00K | ||
| $843.00K | ||
| $12.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $158.35M | ||
| $180.47M | ||
| $416.00K | ||
| $0.00 | ||
| $416.00K | ||
| $0.00 | ||
| -$6.16M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$132.03M | ||
| $188.79M | ||
| -$25.75M | ||
| $0.00 | ||
| -$132.03M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| JP Morgan | ||
| SVB Leerink | ||
| Morgan Stanley | ||
| Morgan Stanley | ||
| JP Morgan | ||
| SVB Leerink |
Analyst sentiment
Institutional ownership
Screeners with AVIR
FAQ
- What is the ticker symbol for Atea Pharmaceuticals, Inc.?
- The ticker symbol for Atea Pharmaceuticals, Inc. is NASDAQ:AVIR
- Does Atea Pharmaceuticals, Inc. pay dividends?
- No, Atea Pharmaceuticals, Inc. does not pay dividends
- What sector is Atea Pharmaceuticals, Inc. in?
- Atea Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Atea Pharmaceuticals, Inc. in?
- Atea Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Atea Pharmaceuticals, Inc. based in?
- Atea Pharmaceuticals, Inc. is headquartered in United States
- When did Atea Pharmaceuticals, Inc. go public?
- Atea Pharmaceuticals, Inc. initial public offering (IPO) was on October 30, 2020
- Is Atea Pharmaceuticals, Inc. in the S&P 500?
- No, Atea Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Atea Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Atea Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Atea Pharmaceuticals, Inc. in the Dow Jones?
- No, Atea Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Atea Pharmaceuticals, Inc. last earnings report?
- Atea Pharmaceuticals, Inc.'s most recent earnings report was on May 12, 2026
- When does Atea Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Atea Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- AVIR Official Website ateapharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1593899/000119312526094159/0001193125-26-094159-index.htm
- AVIR Profile on Yahoo Finance finance.yahoo.com/quote/AVIR
- AVIR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avir